These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22103876)

  • 1. Role of C-reactive protein in cerebrovascular disease: a critical review.
    Di Napoli M; Elkind MS; Godoy DA; Singh P; Papa F; Popa-Wagner A
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1565-84. PubMed ID: 22103876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members.
    Di Napoli M; Schwaninger M; Cappelli R; Ceccarelli E; Di Gianfilippo G; Donati C; Emsley HC; Forconi S; Hopkins SJ; Masotti L; Muir KW; Paciucci A; Papa F; Roncacci S; Sander D; Sander K; Smith CJ; Stefanini A; Weber D
    Stroke; 2005 Jun; 36(6):1316-29. PubMed ID: 15879341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk.
    Hage FG; Szalai AJ
    J Am Coll Cardiol; 2007 Sep; 50(12):1115-22. PubMed ID: 17868801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of C-reactive protein (CRP) levels in patients with acute ischaemic stroke.
    Hamidon BB; Sapiah S; Nawawi H; Raymond AA
    Med J Malaysia; 2004 Dec; 59(5):631-7. PubMed ID: 15889566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population.
    Song IU; Kim JS; Kim YI; Lee KS; Jeong DS; Chung SW
    Cerebrovasc Dis; 2009; 28(6):545-50. PubMed ID: 19844093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside.
    Di Napoli M; Slevin M; Popa-Wagner A; Singh P; Lattanzi S; Divani AA
    Front Immunol; 2018; 9():1921. PubMed ID: 30254628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
    Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
    Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein in liver cancer surgery.
    Morris-Stiff G; Gomez D; Prasad KR
    Eur J Surg Oncol; 2008 Jul; 34(7):727-9. PubMed ID: 18356004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.
    Allin KH; Nordestgaard BG
    Crit Rev Clin Lab Sci; 2011; 48(4):155-70. PubMed ID: 22035340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
    Worthmann H; Tryc AB; Goldbecker A; Ma YT; Tountopoulou A; Hahn A; Dengler R; Lichtinghagen R; Weissenborn K
    Cerebrovasc Dis; 2010; 30(1):85-92. PubMed ID: 20484906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does minor elevation of C-reactive protein signify?
    Kushner I; Rzewnicki D; Samols D
    Am J Med; 2006 Feb; 119(2):166.e17-28. PubMed ID: 16443421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of C-reactive protein in stroke prevention: bright and dark sides of the moon.
    Di Napoli M; Papa F
    Expert Rev Neurother; 2004 Jul; 4(4):613-22. PubMed ID: 15853580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C-reactive protein potential risk factor for cardiovascular disease].
    Tornvall P; Pernow J; Hansson LO
    Lakartidningen; 2003 Aug; 100(35):2691-3. PubMed ID: 14531129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?].
    Yosef-Levi IM; Grad E; Danenberg HD
    Harefuah; 2007 Dec; 146(12):970-4, 996. PubMed ID: 18254451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment.
    Libby P; Ridker PM
    Am J Med; 2004 Mar; 116 Suppl 6A():9S-16S. PubMed ID: 15050187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
    Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke.
    Roudbary SA; Saadat F; Forghanparast K; Sohrabnejad R
    Acta Med Iran; 2011; 49(3):149-52. PubMed ID: 21681701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.